Kirk N. Campbell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kirk N. Campbell has a total of 561 co-authors. Here are the top co-authors by number of shared publications:
Kristin Meliambro
Dr. Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai , New York, NY
15 shared publicationsJenny S. Wong
Division of Renal-Electrolyte and Hypertension, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
12 shared publicationsJustina Ray
Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
6 shared publications- Paolo Cravedi
Translational Transplant Research Center (TTRC), Department of Medicine, Renal Division, Icahn School of Medicine at Mount Sinai, New York, NY
6 shared publications - Evren U. Azeloglu
Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
5 shared publications - Kristin Meliambro
Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY
5 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 15 (10)
Kidney organoids as a platform to study plasminogen-induced injury and uPA-based therapies
Urinary plasminogen has been implicated in the progression of proteinuric kidney diseases, yet its direct role in mediating injury along the nephron remains incompletely understood. Experimental models commonly used to study plasminogen-mediated damage are limited by incomplete phenotypic fidelity or interspecies differences, hindering translational relevance. Here, we used kidney organoids generated from H9 human embryonic stem cells to investigate the effects of plasminogen exposure and to evaluate urokinase-type plasminogen activator (uPA) inhibition with amiloride as a therapeutic strategy. Kidney organoids were exposed to plasminogen in the presence or absence of amiloride, and uPA activity was quantified using a fluorescence-based assay. Compartment-specific injury was assessed by confocal microscopy, automated image analysis, and AI-assisted nuclear segmentation, while targeted transcriptomic changes were evaluated using bulk quantitative PCR. Plasminogen exposure induced glomerular injury, characterized by reduced podocalyxin, nephrin, podocin, and WT1 expression, decreased glomerular cell density, and increased apoptosis. Proximal tubules exhibited reduced LTL and megalin expression, with increased KIM-1, whereas distal tubules were relatively preserved. Amiloride effectively inhibited uPA activity and partially restored podocyte and proximal tubular marker expression, but did not prevent apoptosis, indicating incomplete protection against plasminogen-induced injury. These findings support preferential plasminogen-induced injury along the glomerular–proximal tubular axis and highlight the utility of human kidney organoids for modeling this process, while underscoring the need for further validation and broader molecular profiling to strengthen their application in mechanistic studies and therapeutic discovery.
- 18 September 2026
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 15 (10)
Open AccessKidney organoids as a platform to study plasminogen-induced injury and uPA-based therapies
Urinary plasminogen has been implicated in the progression of proteinuric kidney diseases, yet its direct role in mediating injury along the nephron remains incompletely understood. Experimental models commonly used to study plasminogen-mediated damage are limited by incomplete phenotypic fidelity or interspecies differences, hindering translational relevance. Here, we used kidney organoids generated from H9 human embryonic stem cells to investigate the effects of plasminogen exposure and to evaluate urokinase-type plasminogen activator (uPA) inhibition with amiloride as a therapeutic strategy. Kidney organoids were exposed to plasminogen in the presence or absence of amiloride, and uPA activity was quantified using a fluorescence-based assay. Compartment-specific injury was assessed by confocal microscopy, automated image analysis, and AI-assisted nuclear segmentation, while targeted transcriptomic changes were evaluated using bulk quantitative PCR. Plasminogen exposure induced glomerular injury, characterized by reduced podocalyxin, nephrin, podocin, and WT1 expression, decreased glomerular cell density, and increased apoptosis. Proximal tubules exhibited reduced LTL and megalin expression, with increased KIM-1, whereas distal tubules were relatively preserved. Amiloride effectively inhibited uPA activity and partially restored podocyte and proximal tubular marker expression, but did not prevent apoptosis, indicating incomplete protection against plasminogen-induced injury. These findings support preferential plasminogen-induced injury along the glomerular–proximal tubular axis and highlight the utility of human kidney organoids for modeling this process, while underscoring the need for further validation and broader molecular profiling to strengthen their application in mechanistic studies and therapeutic discovery.
- Open Access
- 26 August 2026
- Published by Elsevier in Kidney International
- Vol. 110 (6) , 1504-1517
Improving the histologic classification of advanced diabetic nephropathy based on the Transformative Research in Diabetic Nephropathy (TRIDENT) findings
- 26 August 2026
- Published by Elsevier in Kidney International
- Vol. 110 (6) , 1504-1517
Open AccessImproving the histologic classification of advanced diabetic nephropathy based on the Transformative Research in Diabetic Nephropathy (TRIDENT) findings
- 15 June 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (8) , 1376-1385
Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort
Background: Percutaneous kidney biopsy is essential for diagnosing kidney disease but carries a risk of bleeding and other complications. Reported complication rates vary widely because of heterogeneity in outcome definitions. Patients with diabetes frequently have hypertension, vascular stiffness, and altered hemostasis, which may further influence biopsy safety. The multicenter Transformative Research in Diabetic Nephropathy (TRIDENT) study prospectively evaluated biopsy complications in adults with diabetes using standardized definitions across 21 sites from the United States. Methods: We analyzed 408 native kidney biopsies from participants with diabetes enrolled in TRIDENT (2017–2025). Complications were classified as minor (hematoma, biopsy site pain, or hemoglobin (Hb) drop), resource-intense (transfusion, radiologic or surgical intervention, or prolonged hospitalization), and major bleeding (≥2 grams/deciliter (g/dL) Hb decline, transfusion, or intervention). Logistic regression with site clustered robust errors was used to identify clinical and procedural associations with outcomes. Results: Among 408 biopsies, 81 complications (20%) occurred, most commonly hematoma (15%); resource-intense events were infrequent (5%). Use of an 18-gauge (vs 16-gauge) needle was associated with lower odds of resource intense events (odds ratio (OR) 0.32; 95% confidence interval (CI) 0.17–0.60). Procedures by fellows, hybrid teams, or interventional radiologists had higher odds than those by attendings (OR 3.12–13.4). Renin–angiotensin system inhibitors (RAASi) use was independently associated with lower odds (OR 0.13; 95% CI 0.02–0.73). Female sex (OR 4.88; 95% CI 1.02-45.3)and post-biopsy hematoma (OR 14.3; 95% CI 3.66-74.5) were associated with major bleeding, whereas the number of passes correlated with hematoma formation but not with adjusted major bleeding risk. Conclusions: In adults with diabetes, clinically significant biopsy complications were uncommon and were associated with procedural and operator factors rather than diabetes. Smaller gauge needles and experienced operators were associated with lower risk, whereas female sex and hematoma were associated with major bleeding. The higher overall complication rate mainly reflected comprehensive, prospective ascertainment of minor events, and supports standardized definitions and procedures to improve biopsy safety in diabetic kidney disease.
- 15 June 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (8) , 1376-1385
Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort
Background: Percutaneous kidney biopsy is essential for diagnosing kidney disease but carries a risk of bleeding and other complications. Reported complication rates vary widely because of heterogeneity in outcome definitions. Patients with diabetes frequently have hypertension, vascular stiffness, and altered hemostasis, which may further influence biopsy safety. The multicenter Transformative Research in Diabetic Nephropathy (TRIDENT) study prospectively evaluated biopsy complications in adults with diabetes using standardized definitions across 21 sites from the United States. Methods: We analyzed 408 native kidney biopsies from participants with diabetes enrolled in TRIDENT (2017–2025). Complications were classified as minor (hematoma, biopsy site pain, or hemoglobin (Hb) drop), resource-intense (transfusion, radiologic or surgical intervention, or prolonged hospitalization), and major bleeding (≥2 grams/deciliter (g/dL) Hb decline, transfusion, or intervention). Logistic regression with site clustered robust errors was used to identify clinical and procedural associations with outcomes. Results: Among 408 biopsies, 81 complications (20%) occurred, most commonly hematoma (15%); resource-intense events were infrequent (5%). Use of an 18-gauge (vs 16-gauge) needle was associated with lower odds of resource intense events (odds ratio (OR) 0.32; 95% confidence interval (CI) 0.17–0.60). Procedures by fellows, hybrid teams, or interventional radiologists had higher odds than those by attendings (OR 3.12–13.4). Renin–angiotensin system inhibitors (RAASi) use was independently associated with lower odds (OR 0.13; 95% CI 0.02–0.73). Female sex (OR 4.88; 95% CI 1.02-45.3)and post-biopsy hematoma (OR 14.3; 95% CI 3.66-74.5) were associated with major bleeding, whereas the number of passes correlated with hematoma formation but not with adjusted major bleeding risk. Conclusions: In adults with diabetes, clinically significant biopsy complications were uncommon and were associated with procedural and operator factors rather than diabetes. Smaller gauge needles and experienced operators were associated with lower risk, whereas female sex and hematoma were associated with major bleeding. The higher overall complication rate mainly reflected comprehensive, prospective ascertainment of minor events, and supports standardized definitions and procedures to improve biopsy safety in diabetic kidney disease.
- 20 April 2026
- Published by Elsevier in Kidney International
- Vol. 109 (5) , 830-832
Communication leading to injury: podocyte-derived fibrillin-1 induces mesangial cell activation and proliferation through EGFR signaling
- 20 April 2026
- Published by Elsevier in Kidney International
- Vol. 109 (5) , 830-832
Communication leading to injury: podocyte-derived fibrillin-1 induces mesangial cell activation and proliferation through EGFR signaling
- Top Cited PapersOpen Access
- 27 March 2026
- Published by Elsevier in Kidney International
- Vol. 110 (3) , 548-565
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- 27 March 2026
- Published by Elsevier in Kidney International
- Vol. 110 (3) , 548-565
Top Cited PapersOpen AccessTargeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- Open Access
- 10 February 2026
- Published by Elsevier in Kidney International
- Vol. 109 (5) , 971-986
Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis
- 10 February 2026
- Published by Elsevier in Kidney International
- Vol. 109 (5) , 971-986
Open AccessPodocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis
- 25 June 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (804) , eadq3852
Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans
Kidney diseases characterized by glomerular epithelial cell proliferation are rare but often devastating, frequently leading to progressive scarring and renal failure. Ranging from autoimmune-induced crescentic glomerulonephritis to HIV infection–induced collapsing glomerulopathy, these diseases are triggered by a wide variety of insults and have generally been thought of as different entities. Here, using immunostaining and spatial transcriptomics, we profiled human kidney biopsies collected from patients with two of these diseases, collapsing glomerulopathy and antineutrophil cytoplasmic antibody (ANCA) vasculitis-induced crescentic glomerulonephritis, to identify common disease-causing molecules. Although triggered by different insults, we identified abnormal hyperactivation of the transcription cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in podocytes as a potential common driver of these diseases. To test this hypothesis, we genetically activated podocyte YAP and TAZ in cultured human cells and in mice by deleting the YAP and TAZ inhibitory large tumor suppressor kinases (LATSs). LATS deficiency in mouse podocytes induced a phenotypic transition in vitro, characterized by a highly distorted structure and an increase in matrix gene expression, mimicking many features of the podocytopathy seen in diseases characterized by glomerular epithelial proliferation. In mice, LATS-deficient podocytes orchestrated a profibrotic and pro-proliferative response in surrounding glomerular cells, a characteristic phenomenon of glomerular epithelial proliferative diseases. This response was attenuated when we also deleted podocyte YAP or TAZ in these mice. Together, our findings point to podocyte YAP-TAZ hyperactivation as a previously unrecognized and unifying driver of glomerular epithelial proliferative diseases.
- 25 June 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (804) , eadq3852
Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans
Kidney diseases characterized by glomerular epithelial cell proliferation are rare but often devastating, frequently leading to progressive scarring and renal failure. Ranging from autoimmune-induced crescentic glomerulonephritis to HIV infection–induced collapsing glomerulopathy, these diseases are triggered by a wide variety of insults and have generally been thought of as different entities. Here, using immunostaining and spatial transcriptomics, we profiled human kidney biopsies collected from patients with two of these diseases, collapsing glomerulopathy and antineutrophil cytoplasmic antibody (ANCA) vasculitis-induced crescentic glomerulonephritis, to identify common disease-causing molecules. Although triggered by different insults, we identified abnormal hyperactivation of the transcription cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in podocytes as a potential common driver of these diseases. To test this hypothesis, we genetically activated podocyte YAP and TAZ in cultured human cells and in mice by deleting the YAP and TAZ inhibitory large tumor suppressor kinases (LATSs). LATS deficiency in mouse podocytes induced a phenotypic transition in vitro, characterized by a highly distorted structure and an increase in matrix gene expression, mimicking many features of the podocytopathy seen in diseases characterized by glomerular epithelial proliferation. In mice, LATS-deficient podocytes orchestrated a profibrotic and pro-proliferative response in surrounding glomerular cells, a characteristic phenomenon of glomerular epithelial proliferative diseases. This response was attenuated when we also deleted podocyte YAP or TAZ in these mice. Together, our findings point to podocyte YAP-TAZ hyperactivation as a previously unrecognized and unifying driver of glomerular epithelial proliferative diseases.
- Top Cited PapersOpen Access
- 7 June 2025
- Published by Elsevier in Kidney International
- Vol. 108 (3) , 485-490
Evaluation of methodologies in anti-nephrin autoantibody detection
- 7 June 2025
- Published by Elsevier in Kidney International
- Vol. 108 (3) , 485-490
Top Cited PapersOpen AccessEvaluation of methodologies in anti-nephrin autoantibody detection
- 2 April 2025
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 32 (1) , 33-40
Genetics in Kidney Diseases
- 2 April 2025
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 32 (1) , 33-40
Genetics in Kidney Diseases
- 24 March 2025
- Published by Elsevier in Kidney International
- Vol. 107 (6) , 994-1001
A new era in nephrology: the role of super-resolution microscopy in research, medical diagnostic, and drug discovery
- 24 March 2025
- Published by Elsevier in Kidney International
- Vol. 107 (6) , 994-1001
A new era in nephrology: the role of super-resolution microscopy in research, medical diagnostic, and drug discovery